Connection
Kyle Kalkwarf to Anticoagulants
This is a "connection" page, showing publications Kyle Kalkwarf has written about Anticoagulants.
|
|
Connection Strength |
|
|
|
|
|
0.556 |
|
|
|
-
Thind T, Heye T, Henson C, Reif R, Jensen HK, Kalkwarf KJ, Bhavaraju A, Robertson R, Jenkins A. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients. Am Surg. 2024 Jun; 90(6):1406-1411.
Score: 0.191
-
Kalkwarf KJ, Yang Y, Mora S, Wolf DA, Robertson RD, Holcomb JB, Drake SA. The silent killer: Previously undetected pulmonary emboli that result in death after discharge. Injury. 2023 Nov; 54(11):111016.
Score: 0.184
-
Heye T, Thind T, Jenkins A, Reif R, Jensen HK, Sexton K, Kalkwarf K, Bhavaraju A. Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe. J Surg Res. 2023 10; 290:209-214.
Score: 0.181